Clinical trial
Treating Chronic Insomnia in Breast Cancer Patients
NCT00337272 · Accelerated Community Oncology Research Network, Other · Terminated
Key facts
| NCT number | NCT00337272 |
|---|---|
| Title | Treating Chronic Insomnia in Breast Cancer Patients |
| Official title | Phase IV: Treatment of Chronic Insomnia in Patients With Breast Cancer Following Completion of Chemotherapy |
| Lead sponsor | Accelerated Community Oncology Research Network, Other |
| Collaborators | Takeda Pharmaceuticals North America, Inc. Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Insomnia |
| Intervention type | Drug |
| Interventions | Placebo, Ramelteon |
| Enrollment | 16 |
| Start date | Aug 1, 2006 |
| Primary completion | Aug 1, 2008 |
| Completion | Jan 1, 2009 |
| First posted | Jun 15, 2006 |
| Last update posted | Aug 22, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: